Lichen secondary metabolites have tremendous pharmaceutical and industrial potential.
Although more than 1000 metabolites have been reported from lichens, less than 10 have …

Secondary metabolites are a crucial source of bioactive compounds playing a key role in the
development of new pharmaceuticals. Recently, biosynthetic research has benefited …

Fungi produce a vast number of secondary metabolites that shape their interactions with
other organisms and the environment. Characterizing the genes underpinning metabolite …

Lichen natural products are a tremendous source of new bioactive chemical entities for drug
discovery. The ability to survive in harsh conditions can be directly correlated with the …

Thielavin A (1) is a fungal depside composed of one 3‐methylorsellinic acid and two 3, 5‐
dimethylorsellinic acid units. It displays diverse biological activities. However, the …

Fungi involved in lichen symbioses produce a large array of secondary metabolites that are
often diagnostic in the taxonomic delimitation of lichens. The most common lichen …

Lichens are symbiotic associations consisting of a photobiont (algae or cyanobacteria) and
a mycobiont (fungus). They are known to produce a variety of unique secondary metabolites …

Two new depside antibiotics, geministatins A (1) and B (2), were isolated from the fungus
Austroacremonium gemini MST-FP2131 (Sordariomycetes, Ascomycota), which was …

Tridepsides, as fully oxidized polyketides, have been known to exist in lichens for more than
a century. Recent studies have showed that these possible defensive lichenochemicals …

Natural products (NPs) and their derivatives are a major contributor to modern medicine.
Historically, microorganisms such as bacteria and fungi have been instrumental in …